GlobeNewswire Inc.··Beyond Air, Inc.Beyond Cancer's UNO Therapy Shows Durable Survival Gains in Early-Stage Cancer Trial
Beyond Cancer presented Phase 1 UNO trial data with six of ten patients alive 22-40 months post-treatment and secured U.S. patent for gas delivery technology.
XAIRbreast cancercancer treatment